Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
February 18, 2022 10:06 AM 9 min read

Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022

by Benzinga Insights Benzinga Staff Writer
Follow

 

Upgrades

  • Roth Capital upgraded the previous rating for Denbury Inc (NYSE:DEN) from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $91.30 and a 52-week-low of $37.00. At the end of the last trading period, Denbury closed at $66.56.
  • For Pilgrims Pride Corp (NASDAQ:PPC), Stephens & Co. upgraded the previous rating of Equal-Weight to Overweight. In the fourth quarter, Pilgrims Pride showed an EPS of $0.56, compared to $0.25 from the year-ago quarter. The current stock performance of Pilgrims Pride shows a 52-week-high of $29.70 and a 52-week-low of $20.32. Moreover, at the end of the last trading period, the closing price was at $27.83.
  • According to Scotiabank, the prior rating for Marathon Oil Corp (NYSE:MRO) was changed from Sector Perform to Sector Outperform. For the fourth quarter, Marathon Oil had an EPS of $0.77, compared to year-ago quarter EPS of $0.12. At the moment, the stock has a 52-week-high of $22.56 and a 52-week-low of $9.11. Marathon Oil closed at $21.89 at the end of the last trading period.
  • According to Needham, the prior rating for Masimo Corp (NASDAQ:MASI) was changed from Hold to Buy. Masimo earned $1.21 in the fourth quarter, compared to $0.98 in the year-ago quarter. The current stock performance of Masimo shows a 52-week-high of $305.21 and a 52-week-low of $133.94. Moreover, at the end of the last trading period, the closing price was at $152.37.
  • According to JP Morgan, the prior rating for JB Hunt Transport Services Inc (NASDAQ:JBHT) was changed from Underweight to Neutral. In the fourth quarter, JB Hunt Transport Servs showed an EPS of $2.28, compared to $1.44 from the year-ago quarter. The stock has a 52-week-high of $208.87 and a 52-week-low of $140.88. At the end of the last trading period, JB Hunt Transport Servs closed at $187.84.
  • Raymond James upgraded the previous rating for Fastly Inc (NYSE:FSLY) from Outperform to Strong Buy. For the fourth quarter, Fastly had an EPS of $0.10, compared to year-ago quarter EPS of $0.09. The current stock performance of Fastly shows a 52-week-high of $97.98 and a 52-week-low of $19.13. Moreover, at the end of the last trading period, the closing price was at $19.20.
  • Atlantic Equities upgraded the previous rating for Nutrien Ltd (NYSE:NTR) from Underweight to Neutral. In the fourth quarter, Nutrien showed an EPS of $2.47, compared to $0.24 from the year-ago quarter. At the moment, the stock has a 52-week-high of $78.76 and a 52-week-low of $52.28. Nutrien closed at $77.17 at the end of the last trading period.
  • For Werner Enterprises Inc (NASDAQ:WERN), JP Morgan upgraded the previous rating of Underweight to Neutral. Werner Enterprises earned $1.13 in the fourth quarter, compared to $0.89 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.76 and a 52-week-low of $41.44. Werner Enterprises closed at $42.70 at the end of the last trading period.
  • According to JP Morgan, the prior rating for Cognex Corp (NASDAQ:CGNX) was changed from Underweight to Neutral. Cognex earned $0.30 in the fourth quarter, compared to $0.32 in the year-ago quarter. The stock has a 52-week-high of $92.17 and a 52-week-low of $61.59. At the end of the last trading period, Cognex closed at $61.65.

See all analyst ratings upgrades.

 

Downgrades

See all analyst ratings downgrades.

 

Initiations

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
API Logo
APIAgora Inc
$4.59-%
Overview
BEKE Logo
BEKEKE Holdings Inc
$17.560.06%
BILI Logo
BILIBilibili Inc
$30.840.78%
BRC Logo
BRCBrady Corp
$96.510.19%
BRSP Logo
BRSPBrightSpire Capital Inc
$5.73-%
CEG Logo
CEGConstellation Energy Corp
$289.000.20%
CGNX Logo
CGNXCognex Corp
$58.930.24%
CPS Logo
CPSCooper-Standard Holdings Inc
$45.10-0.22%
CRBU Logo
CRBUCaribou Biosciences Inc
$1.58-%
FSLY Logo
FSLYFastly Inc
$18.280.11%
HTLD Logo
HTLDHeartland Express Inc
$11.28-%
IRDM Logo
IRDMIridium Communications Inc
$23.15-0.09%
IREN Logo
IRENIREN Ltd
$41.57-1.54%
JBHT Logo
JBHTJB Hunt Transport Services Inc
$221.76-%
LASR Logo
LASRnLight Inc
$51.80-0.92%
MASI Logo
MASIMasimo Corp
$170.5831.1%
NTLA Logo
NTLAIntellia Therapeutics Inc
$11.70-1.43%
NTR Logo
NTRNutrien Ltd
$71.070.37%
ORMP Logo
ORMPOramed Pharmaceuticals Inc
$3.14-3.38%
PPC Logo
PPCPilgrims Pride Corp
$43.32-%
ROKU Logo
ROKURoku Inc
$89.22-0.93%
SBRA Logo
SBRASabra Health Care REIT Inc
$20.17-%
TME Logo
TMETencent Music Entertainment Group
$15.84-0.06%
VNT Logo
VNTVontier Corp
$41.79-%
VTVT Logo
VTVTvTv Therapeutics Inc
$38.0012.2%
WERN Logo
WERNWerner Enterprises Inc
$33.21-%
ZH Logo
ZHZhihu Inc
$3.45-2.27%
  • MoffettNathanson downgraded the previous rating for Altice USA Inc (NYSE:ATUS) from Buy to Neutral. Altice USA earned $0.56 in the fourth quarter, compared to $0.60 in the year-ago quarter. The current stock performance of Altice USA shows a 52-week-high of $38.19 and a 52-week-low of $11.12. Moreover, at the end of the last trading period, the closing price was at $11.83.
  • Benchmark downgraded the previous rating for Cooper-Standard Holdings Inc (NYSE:CPS) from Buy to Hold. Cooper-Standard Holdings earned $2.94 in the fourth quarter, compared to $0.19 in the year-ago quarter. The stock has a 52-week-high of $47.85 and a 52-week-low of $14.40. At the end of the last trading period, Cooper-Standard Holdings closed at $15.30.
  • According to Wells Fargo, the prior rating for Brady Corp (NYSE:BRC) was changed from Overweight to Equal-Weight. For the second quarter, Brady had an EPS of $0.70, compared to year-ago quarter EPS of $0.59. The stock has a 52-week-high of $61.76 and a 52-week-low of $48.27. At the end of the last trading period, Brady closed at $48.89.
  • According to Pivotal Research, the prior rating for Roku Inc (NASDAQ:ROKU) was changed from Hold to Sell. For the fourth quarter, Roku had an EPS of $0.17, compared to year-ago quarter EPS of $0.49. The current stock performance of Roku shows a 52-week-high of $490.76 and a 52-week-low of $139.47. Moreover, at the end of the last trading period, the closing price was at $144.71.
  • According to Goldman Sachs, the prior rating for Bilibili Inc (NASDAQ:BILI) was changed from Buy to Neutral. For the third quarter, Bilibili had an EPS of $0.65, compared to year-ago quarter EPS of $0.41. At the moment, the stock has a 52-week-high of $153.57 and a 52-week-low of $28.32. Bilibili closed at $36.54 at the end of the last trading period.
  • Goldman Sachs downgraded the previous rating for Tencent Music Entertainment Group (NYSE:TME) from Neutral to Sell. In the third quarter, Tencent Music Enter Gr showed an EPS of $0.09, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.25 and a 52-week-low of $5.36. Tencent Music Enter Gr closed at $5.99 at the end of the last trading period.
  • According to JP Morgan, the prior rating for Heartland Express Inc (NASDAQ:HTLD) was changed from Overweight to Neutral. Heartland Express earned $0.26 in the fourth quarter, compared to $0.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $20.07 and a 52-week-low of $14.02. Heartland Express closed at $14.49 at the end of the last trading period.
  • RBC Capital downgraded the previous rating for Redfin Corp (NASDAQ:RDFN) from Outperform to Sector Perform. In the fourth quarter, Redfin showed an EPS of $0.27, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $98.44 and a 52-week-low of $25.25. At the end of the last trading period, Redfin closed at $28.64.
  • UBS initiated coverage on Constellation Energy Corp (NASDAQ:CEG) with a Neutral rating. The price target for Constellation Energy is set to $50.00. The current stock performance of Constellation Energy shows a 52-week-high of $56.57 and a 52-week-low of $43.88. Moreover, at the end of the last trading period, the closing price was at $45.29.
  • William Blair initiated coverage on Intellia Therapeutics Inc (NASDAQ:NTLA) with an Outperform rating. Intellia Therapeutics earned $0.97 in the third quarter, compared to $0.47 in the year-ago quarter. The stock has a 52-week-high of $202.73 and a 52-week-low of $43.86. At the end of the last trading period, Intellia Therapeutics closed at $90.40.
  • With a Buy rating, Stifel initiated coverage on Fathom Digital Manufacturing Corp (NYSE:FATH). The price target seems to have been set at $11.00 for Fathom Digital. The current stock performance of Fathom Digital shows a 52-week-high of $11.50 and a 52-week-low of $5.04. Moreover, at the end of the last trading period, the closing price was at $9.12.
  • With a Buy rating, B of A Securities initiated coverage on AdTheorent Holding Co Inc (NASDAQ:ADTH). The price target seems to have been set at $10.00 for AdTheorent Holding. The current stock performance of AdTheorent Holding shows a 52-week-high of $11.90 and a 52-week-low of $4.11. Moreover, at the end of the last trading period, the closing price was at $6.42.
  • With an Overweight rating, Cantor Fitzgerald initiated coverage on Oramed Pharmaceuticals Inc (NASDAQ:ORMP). The price target seems to have been set at $20.00 for Oramed Pharmaceuticals. Oramed Pharmaceuticals earned $0.22 in the first quarter, compared to $0.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $31.54 and a 52-week-low of $6.98. Oramed Pharmaceuticals closed at $10.63 at the end of the last trading period.
  • Cantor Fitzgerald initiated coverage on vTv Therapeutics Inc (NASDAQ:VTVT) with an Overweight rating. The price target for vTv Therapeutics is set to $5.00. In the third quarter, vTv Therapeutics showed an EPS of $0.02, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $3.79 and a 52-week-low of $0.67. vTv Therapeutics closed at $0.71 at the end of the last trading period.
  • Benchmark initiated coverage on Bridgetown 2 Holdings Ltd (NASDAQ:BTNB) with a Buy rating. The price target for Bridgetown 2 Holdings is set to $17.00. The stock has a 52-week-high of $13.70 and a 52-week-low of $9.79. At the end of the last trading period, Bridgetown 2 Holdings closed at $9.97.
  • RBC Capital initiated coverage on Caribou Biosciences Inc (NASDAQ:CRBU) with an Outperform rating. The price target for Caribou Biosciences is set to $22.00. At the moment, the stock has a 52-week-high of $32.65 and a 52-week-low of $9.34. Caribou Biosciences closed at $10.22 at the end of the last trading period.
  • With an Outperform rating, RBC Capital initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV). The price target seems to have been set at $42.00 for Verve Therapeutics. For the third quarter, Verve Therapeutics had an EPS of $0.47, compared to year-ago quarter EPS of $3.81. The stock has a 52-week-high of $78.00 and a 52-week-low of $24.75. At the end of the last trading period, Verve Therapeutics closed at $28.02.
  • RBC Capital initiated coverage on Graphite Bio Inc (NASDAQ:GRPH) with a Sector Perform rating. The price target for Graphite Bio is set to $11.00. At the moment, the stock has a 52-week-high of $34.00 and a 52-week-low of $7.59. Graphite Bio closed at $10.99 at the end of the last trading period.
API Logo
APIAgora Inc
$4.59-%
Overview
BEKE Logo
BEKEKE Holdings Inc
$17.560.06%
BILI Logo
BILIBilibili Inc
$30.840.78%
BRC Logo
BRCBrady Corp
$96.510.19%
BRSP Logo
BRSPBrightSpire Capital Inc
$5.73-%
CEG Logo
CEGConstellation Energy Corp
$289.000.20%
CGNX Logo
CGNXCognex Corp
$58.930.24%
CPS Logo
CPSCooper-Standard Holdings Inc
$45.10-0.22%
CRBU Logo
CRBUCaribou Biosciences Inc
$1.58-%
FSLY Logo
FSLYFastly Inc
$18.280.11%
HTLD Logo
HTLDHeartland Express Inc
$11.28-%
IRDM Logo
IRDMIridium Communications Inc
$23.15-0.09%
IREN Logo
IRENIREN Ltd
$41.57-1.54%
JBHT Logo
JBHTJB Hunt Transport Services Inc
$221.76-%
LASR Logo
LASRnLight Inc
$51.80-0.92%
MASI Logo
MASIMasimo Corp
$170.5831.1%
NTLA Logo
NTLAIntellia Therapeutics Inc
$11.70-1.43%
NTR Logo
NTRNutrien Ltd
$71.070.37%
ORMP Logo
ORMPOramed Pharmaceuticals Inc
$3.14-3.38%
PPC Logo
PPCPilgrims Pride Corp
$43.32-%
ROKU Logo
ROKURoku Inc
$89.22-0.93%
SBRA Logo
SBRASabra Health Care REIT Inc
$20.17-%
TME Logo
TMETencent Music Entertainment Group
$15.84-0.06%
VNT Logo
VNTVontier Corp
$41.79-%
VTVT Logo
VTVTvTv Therapeutics Inc
$38.0012.2%
WERN Logo
WERNWerner Enterprises Inc
$33.21-%
ZH Logo
ZHZhihu Inc
$3.45-2.27%
Comments
Loading...